BLPH Stock
Price Chart
BLPH Financial and Trading Overview
| stock price | 0.01 |
| Previous Close | 0.7 |
| Open | 0.72 |
| Bid | 0 x 800 |
| Ask | 0 x 1800 |
| Day's Range | 0.69 - 0.72 |
| 52 Week Range | 0.67 - 12.58 |
| Volume | 598.4K |
| Avg. Volume | 547.22K |
| Market Cap | 7.37M |
| Beta (5Y Monthly) | 0.895847 |
| PE Ratio (TTM) | N/A |
| EPS (TTM) | 0 |
| Forward Dividend & Yield | N/A (N/A) |
| Ex-Dividend Date | N/A |
| 1y Target Est | 10.5 |
BLPH Valuation Measures
| Enterprise Value | -7619220 |
| Trailing P/E | N/A |
| Forward P/E | -0.48273972 |
| PEG Ratio (5 yr expected) | 0 |
| Price/Sales (ttm) | 1.3058544 |
| Price/Book (mrq) | 0.6943843 |
| Enterprise Value/Revenue | -1.351 |
| Enterprise Value/EBITDA | 0.501 |
Trading Information
Stock Price History
| Beta (5Y Monthly) | 0.895847 |
| 52-Week Change | -18.023% |
| S&P500 52-Week Change | 20.43% |
| 52 Week High | 12.58 |
| 52 Week Low | 0.67 |
| 50-Day Moving Average | 7.45 |
| 200-Day Moving Average | 3.5 |
BLPH Share Statistics
| Avg. Volume (3 month) | 547.22K |
| Avg. Daily Volume (10-Days) | 2.43M |
| Shares Outstanding | 10.45M |
| Float | 7.05M |
| Short Ratio | 2.64 |
| % Held by Insiders | 4.11% |
| % Held by Institutions | 44.42% |
| Shares Short | 346.98K |
| Short % of Float | 4.19% |
| Short % of Shares Outstanding | 3.31% |
Dividends & Splits
| Trailing Annual Dividend Rate | 0 |
| Trailing Annual Dividend Yield | 0% |
| 5 Year Average Dividend Yield | N/A |
| Payout Ratio | 0 |
| Last Split Factor | 1:15 |
Financial Highlights
Fiscal Year
| Fiscal Year Ends | December 31, 2022 |
| Most Recent Quarter (mrq) | March 31, 2023 |
| Next Fiscal Year End | December 31, 2023 |
Profitability
| Profit Margin | -201.56% |
| Operating Margin (ttm) | -270.70% |
| Gross Margin | 100.00% |
| EBITDA Margin | -269.91% |
Management Effectiveness
| Return on Assets (ttm) | -50.60% |
| Return on Equity (ttm) | -84.92% |
Income Statement
| Revenue (ttm) | 5.64M |
| Revenue Per Share (ttm) | 0.58 |
| Quarterly Revenue Growth (yoy) | N/A |
| Gross Profit (ttm) | N/A |
| EBITDA | -15223000 |
| Net Income Avi to Common (ttm) | -11368000 |
| Diluted EPS (ttm) | -1.07 |
| Quarterly Earnings Growth (yoy) | N/A |
Balance Sheet
| Total Cash (mrq) | 15.17M |
| Total Cash Per Share (mrq) | 1.45 |
| Total Debt (mrq) | 8K |
| Total Debt/Equity (mrq) | 0.08 |
| Current Ratio (mrq) | 2.94 |
| Book Value Per Share (mrq) | 1.015 |
Cash Flow Statement
| Operating Cash Flow (ttm) | -9768000 |
| Levered Free Cash Flow (ttm) | -8167500 |
Profile of
| Country | United States |
| State | NJ |
| City | Warren |
| Address | 20 Independence Boulevard |
| ZIP | 07059 |
| Phone | (908) 574-4770 |
| Website | https://bellerophon.com |
| Industry | Biotechnology |
| Sector(s) | Healthcare |
| Full Time Employees | 18 |
Bellerophon Therapeutics, Inc., a clinical-stage therapeutics company, focuses on the development of products for the treatment of cardiopulmonary diseases in the United States. Its primary product is INOpulse, a proprietary pulsatile nitric oxide delivery platform for the treatment of pulmonary hypertension. The company engages in the development of INOpulse, which is in Phase 3 clinical trial for the treatment of pulmonary hypertension associated with fibrotic interstitial lung disease; which has completed Phase 2a clinical trial for pulmonary hypertension associated with chronic obstructive pulmonary disease; and that has completed Phase 2 dose escalation stage for pulmonary hypertension associated with sarcoidosis, as well as for chronic thromboembolic pulmonary hypertension and pulmonary hypertension associated with pulmonary edema from high altitude sickness. The company was formerly known as Ikaria Development LLC and changed its name to Bellerophon Therapeutics, Inc. in January 2014. Bellerophon Therapeutics, Inc. was founded in 2009 and is headquartered in Warren, New Jersey.
Q&A For Stock
What is a current BLPH stock price?
BLPH stock price today per share is 0.01 .
How to purchase stock?
You can buy BLPH shares on the OTC Markets EXMKT exchange. Contact your financial advisor to select a broker.
What is the ticker symbol for ?
The stock symbol or ticker of is BLPH.
Which industry does the company belong to?
The industry is Biotechnology.
How many shares does have in circulation?
The max supply of shares is 0.
What is Price to Earnings Ratio (PE Ratio)?
PE Ratio is 0.00000000 now.
What was earnings per share over the trailing 12 months (TTM)?
EPS is 0 over the trailing 12 months.
Which sector does the company belong to?
The sector is Healthcare.
BLPH included in indexes
| Name Name | Price Price |
24h% 7d chart 24h% & 7d |
VOL Volume | 24h low | 24h high | Volume |
|---|
| Name Name | Price Price |
24h% 7d chart 24h% & 7d |
VOL Volume | 24h low | 24h high | Volume | |
|---|---|---|---|---|---|---|---|
| {{ item.name }} {{ item.symbol }} | {{ item.price }} {{ item.price_usd }} |
{{ item.change_pct }}
|
{{ item.volume }} {{ item.volume_usd }} | {{ item.low }} {{ item.low_usd }} | {{ item.high }} {{ item.high_usd }} | {{ item.components_count }} - | {{ item.volume }} {{ item.volume_usd }} |
| NASDAQ Composite IXIC | 17382.94 USD — |
+1.26
|
6.5B USD — | 17110.72 USD — | 17404.49 USD — | — - | 6.5B USD — |
| NASDAQ Composite Total Return I XCMP | 21278.67 USD — |
+1.26
|
— — | 20945.45 USD — | 21305.05 USD — | — - | — — |
| NASDAQ Capital Market Composite RCMP | 102.15 USD — |
-0.54
|
— — | 101.35 USD — | 102.39 USD — | — - | — — |
| NASDAQ HealthCare IXHC | 923.51 USD — |
-0.73
|
— — | 917.75 USD — | 925.61 USD — | — - | — — |
- {{ link.label }} {{link}}